Why Do Some People Get Dementia in Middle Age?

Health & Lifestyle
611

Listen to article (english)

Translate to Spanish or other 102 languages!

Key protein changes could trigger frontotemporal dementia in middle age, a recent study has found. Image for illustration purposes
Key protein changes could trigger frontotemporal dementia in middle age, a recent study has found. Image for illustration purposes

Mega Doctor News

- Advertisement -
  • A new study from UC San Francisco may offer the first clear biological markers for frontotemporal dementia, a condition that often affects people in midlife and is difficult to diagnose.
  • By analysing spinal fluid from patients with inherited frontotemporal dementia, researchers uncovered protein changes linked to RNA regulation and brain connectivity; early indicators that could lead to earlier, more accurate diagnosis.
  • These findings could open the door to precision treatments and expanded access to clinical trials for those living with the disease.

Dementia typically affects older adults, so when it appears in middle age it can be difficult to identify.

Follow the link below to Medical News today for the full story:

https://www.medicalnewstoday.com/articles/why-do-some-people-get-dementia-in-middle-age

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Electrical Stimulation Offers Hope for Treating Spinal Injuries
Next article
STC Graduate Begins a Bold New Chapter in Health Information

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -